InogenNASDAQ: INGN

Expanding product portfolio and high prospects for POC raise optimism for Inogen (INGN) stock.

Inogen's (INGN) fourth-quarter earnings and revenues miss their respective consensus estimate. Gross margin expands while the company continues to incur losses at the operating level.

While the top- and bottom-line numbers for Inogen (INGN) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Inogen (INGN) came out with a quarterly loss of $1.14 per share versus the Zacks Consensus Estimate of a loss of $0.65. This compares to loss of $0.57 per share a year ago.

Get a deeper insight into the potential performance of Inogen (INGN) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Inogen's (INGN) potential in the POC space and a strong product portfolio raise optimism about the stock.

Inogen (INGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

GOLETA, Calif.--(BUSINESS WIRE)--Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024.

Inogen (INGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.